WO2013083584A1 - Composition antimicrobienne - Google Patents

Composition antimicrobienne Download PDF

Info

Publication number
WO2013083584A1
WO2013083584A1 PCT/EP2012/074405 EP2012074405W WO2013083584A1 WO 2013083584 A1 WO2013083584 A1 WO 2013083584A1 EP 2012074405 W EP2012074405 W EP 2012074405W WO 2013083584 A1 WO2013083584 A1 WO 2013083584A1
Authority
WO
WIPO (PCT)
Prior art keywords
terpineol
antimicrobial
composition
composition according
weight
Prior art date
Application number
PCT/EP2012/074405
Other languages
English (en)
Inventor
Robert Joseph CORNMELL
Megan Anne Diehl
Stephen Golding
John Robert HARP
Ian Peter Stott
Katherine Mary Thompson
Carol Lynn TRUSLOW
Original Assignee
Unilever N.V.
Unilever Plc
Hindustan Unilever Limited
Conopco, Inc., D/B/A Unilever
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever N.V., Unilever Plc, Hindustan Unilever Limited, Conopco, Inc., D/B/A Unilever filed Critical Unilever N.V.
Publication of WO2013083584A1 publication Critical patent/WO2013083584A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A01N31/16—Oxygen or sulfur directly attached to an aromatic ring system with two or more oxygen or sulfur atoms directly attached to the same aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Definitions

  • the present invention relates to an antimicrobial composition and a method for disinfection involving the antimicrobial composition. It particularly relates to an antimicrobial composition for personal cleaning, oral care or hard surface cleaning applications.
  • Sanitising and disinfecting soap or cleaning compositions are of great benefit to individuals, since proper use generally may reduce the number of germs and pathogens the individual is exposed to. Thus, such compositions may for instance play an important role in reducing the occurrence and spread of infectious diseases.
  • Sanitising and disinfecting soap compositions comprising chlorine-based antimicrobial agent such as triclosan are known. Such compositions require a rather long contact time to provide efficacious antimicrobial action.
  • users, in particular children do not spend a long time on cleansing and as a result cleaning with such compositions does not provide adequate prevention from surface or topical infection or adequate protection against diseases. The user, in spite of cleaning his hands, is generally likely to end up with relatively inadequate bacterial removal from his skin.
  • the antimicrobial in the compositions are in contact with the substrate for less than a few minutes after which the surface is either wiped off or rinsed with water.
  • These short time scales of cleaning action are ineffective in providing the desired benefit since most known antimicrobials commonly used in such products take many minutes to hours to provide the desired kill of microbes. Therefore, there is a need of providing a composition that -upon application- provides relatively more efficacious antimicrobial action during a relatively short cleaning period, preferably about 30 seconds or less.
  • phenols - even if they are antimicrobially active - may exhibit undesirable side-effects, such as corrosiveness, malodour and irritating or sensitising effects when applied on the human or animal skin.
  • WO 2010/046238 A1 describes an effective antimicrobial composition which provides rapid kill of pathogenic bacteria and which comprises 0.01 to 5% by weight of thymol, 0.01 to 5% by weight of terpineol and a carrier.
  • WO 2010/046238 A1 also discloses a method of disinfecting a surface including the step of applying the above composition to the surface.
  • EP 2 042 198 A1 discloses a "double component type" deodorant comprising a component A containing a liquid mixture containing a polyphenol and an acid agent; and a component B containing an alkali agent and an aqueous solvent.
  • EP 259249 discloses a microbicidal composition and its application for the disinfection of skin, hands and hard surfaces.
  • the composition comprises inter alia 0.1 to 2.5 wt% of a microbicidally active compound, and 1 to 25 wt% of a solubility-enhancing additive.
  • the microbicidal compound may for instance be of the general formula:
  • R1 is hydrogen, hydroxy, C1 -4-alkyl, chloro, nitro, phenyl or benzyl
  • R2 is hydrogen, hydroxy, C1 -C6-alkyl or chloro
  • R3 is hydrogen, C1 -C6-alkyl, hydroxy, chloro, nitro or a sulfo-group in the form of their alkali metal- or ammonium salts
  • R4 is hydrogen or methyl
  • R5 is hydrogen or nitro.
  • the solubility-enhancing additive may, among others, be selected from aliphatic and monocyclic mono-alcohols, like C2-C18 alkanols, C2-C18 alkenols and terpene alcohols, for instance ethanol, propanol, isopropanol, hexanol, cis-3-hexen-1 -ol, trans-2-hexen-1 -ol, 1 -octen-3-ol, heptanol, octanol, trans-2-cis-6-nonadien-1 -ol, decanol, linalool, geraniol, dihydroterpineol, myrcenol, nopol and terpineol.
  • aliphatic and monocyclic mono-alcohols like C2-C18 alkanols, C2-C18 alkenols and terpene alcohols, for instance ethanol, propanol, isopropano
  • FR 2 697 133 discloses biocidal and/or biostatic compositions, comprising mono- oxygenated sesquiterpenes of general formula Ci 5 H x O, wherein x is between 20 and 26 and aromatic compounds.
  • a particular problem of certain antimicrobial actives, and especially some phenolic compounds such as thymol is that they are generally well-perceptible due to their olfactory properties. Although the latter may - at least for some species - be appreciated in certain fragrance compositions, they are considered too intense by some users when they are applied at concentrations efficacious in rapid disinfection. Additionally, a lower concentration of odoriferous compounds or the availability of antimicrobial compounds that are less or not odoriferous allows greater flexibility to the manufacturer in providing alternative scents to his composition at lower doses. Hence there is a need to provide alternative antimicrobial compositions and methods that preferably require lower concentrations and/or have a more acceptable sensory profile.
  • an object of the present invention to provide an antimicrobial composition in which the olfactory contribution of the antimicrobially active compounds is reduced or in which the active compound contributes to providing a consumer-acceptable or even consumer-appreciated scent.
  • an object of the invention to provide an antimicrobial composition which gives improved disinfection during cleansing of surfaces of the human body, such as the skin and the oral cavity.
  • compositions comprising selected mono- substituted catechols and terpineol provide synergistic antimicrobial action. Such compositions provide similarly efficacious anti-microbial action, at similar
  • compositions according to the present invention do not rely on the presence of halogenated phenols for their antimicrobial efficacy.
  • At least some of the monosubstituted catechols advantageously have an olfactory detection limit that is lower than that of comparable phenolic compounds.
  • an antimicrobial composition comprising:
  • substituent R-i is selected from the group consisting of linear C 2 to C 5 alkyl, branched C 3 to C 4 alkyl, linear C 3 to C 5 alkenyl, linear C 4 to C 5 alkadienyl, branched C 4 alkenyl, cyclopentyl, cyclopentenyl, cyclohexyl, cyclohexenyl, phenyl, and benzyl; and wherein the terpineol is selected from the group consisting of alpha-terpineol, beta- terpineol, gamma-terpineol, delta-terpineol, 4-terpineol, and mixtures thereof.
  • a method of disinfecting a surface comprising the steps of
  • the invention provides the use of a composition according to the invention for improved hygiene.
  • disinfection refers to reduction of the number of viable microorganisms in a given medium or on a given surface by physical or chemical means. Typically, disinfection involves the destruction or inactivation of said
  • microorganisms Both animate and inanimate media and surfaces are contemplated.
  • microbicide refers to a compound capable of killing, inhibiting the growth of or controlling the growth of microorganisms at a locus; microbicides include
  • microorganism includes, for example, fungi (such as yeast and mould), bacteria and algae.
  • the antimicrobial composition comprises one or more monosubstituted catechols, terpineol and a carrier. Various components of the antimicrobial composition are described below.
  • compositions of the present invention are preferred for non-therapeutic use, and more particularly preferred for use in cleaning surfaces of human body including skin, hair or oral cavity or for hard surface cleaning applications.
  • Monosubstituted catechols are preferred for non-therapeutic use, and more particularly preferred for use in cleaning surfaces of human body including skin, hair or oral cavity or for hard surface cleaning applications.
  • the antimicrobial composition according to the invention comprises 0.001 to 5% by weight of one or more monosubstituted catechols.
  • the composition comprises preferably 0.005 to 4.5 wt-%, more preferably 0.01 to 4 wt-%, even more preferably 0.02 to 3 wt-%, yet more preferably 0.03 to 2 wt-%, still more preferably 0.04 to 1 wt-%, even more preferably 0.05 to 0.75 wt-% and still more preferably 0.1 to 0.5 wt-% of the one or more monosubstituted catechols.
  • the minimum preferred concentrations of the one or more monosubstituted catechols can be higher.
  • compositions according to the invention intended for dilution upon use preferably comprise 0.05 to 4.5 wt-%, more preferably 0.1 to 4 wt-%, even more preferably 0.2 to 3 wt-%, still more preferably 0.4 to 1 wt-%, and still more preferably 0.5 to 1 wt-% of the one or more monosubstituted catechols.
  • the concentration of the one or more monosubstituted catechols in the antimicrobial composition is preferably such that, when the composition is diluted or dissolved with a suitable medium during use, the concentration in the diluted or dissolved mixture is still sufficient to be antimicrobially efficacious.
  • the monosubstituted catechol can be a single compound or can be a mixture of the monosubstituted catechols as detailed below. In certain preferred embodiments, mixtures of monosubstituted catechols are preferred, since such mixtures may show increased antimicrobial activity against a wider range of microbes. On the other hand, for reasons including e.g. control over the formulation, it is preferred that in case the composition according to the invention comprises a mixture of such monosubstituted catechols, the mixture preferably comprises at least 30%, more preferably at least 50%, even more preferably at least 70% and still more preferably at least 90% by weight of one monosubstituted catechol with respect to the total weight of the one or more monosubstituted catechols.
  • the present inventors have found that unlike in therapeutic/pesticidal/herbicidal applications where sensorial aspects are not critical, in the present application, which is preferably a personal cleaning, oral care or hard surface cleaning applications, the product is in contact with hands, mouth or other body parts, the sensorial aspects including smell and skin feel would be compromised.
  • the one or more monosubstituted catechols have the following structure
  • substituent R-i is selected from the group consisting of linear C 2 to C 5 alkyl, branched C 3 to C 5 alkyl, linear C 3 to C 5 alkenyl, linear C 4 to C 5 alkadienyl, branched C 4 alkenyl, cyclopentyl, cyclopentenyl, cyclohexyl, cyclohexenyl, phenyl, and benzyl.
  • Monosubstituted catechols are also called monosubstituted benzene-1 ,2-diols or monosubstituted 2-hydroxyphenols.
  • Linear C 2 to C 5 alkyl substituents are for instance ethyl, n-propyl, n-butyl, or n-pentyl.
  • Branched C 3 to C 4 alkyl, substituents are for instance isopropyl, tert- butyl, sec- butyl, or / ' so-butyl.
  • the unsaturated R substituents according to the invention for example the alkenyl, alkadienyl, and cycloalkenyl substituents, comprise a C-C double bond, which may take any position in the substituent.
  • the cyclopentenyl substituents for instance include (cyclopent-1 -en-1 -yl)-, (cyclopent-2-en-1 -yl)-, and (cyclopent-3-en-1 -yl)- substituents.
  • the branched C 4 alkenyl substituents include for instance (1 - ethylethenyl), (1 -methylprop-1 -enyl), (1 -methylprop-2-enyl), (2-methylprop-1 -enyl), and (2-methyl-prop-2-enyl).
  • the substituent R-i is preferably selected from the group consisting of linear C 3 to C 5 alkyl, branched C 4 alkyl, linear C 3 to C 5 alkenyl, linear C 4 to C 5 alkadienyl, branched C 4 alkenyl, cyclopentyl, cyclopentenyl, cyclohexyl, cyclohexenyl, phenyl, and benzyl. More preferably, Ri is selected from the group consisting of linear C 3 to C 5 alkyl, branched C 4 alkyl, cyclopentyl, cyclohexyl, phenyl, and benzyl.
  • the substituent R-i is selected from linear or branched C 4 alkyl and linear or branched C 4 alkenyl. Even more preferably, the substituent R-i is selected from ie f-butyl, sec-butyl and isobutyl. Still more preferably, the substituent Ri is ie f-butyl.
  • the one or more monosubstituted catechols can be selected from 3-fe/f-butylcatechol, and 4-ie f-butylcatechol. It is preferred that the one or more monosubstituted catechols are 4-substituted catechols; that is, monosubstituted catechols wherein R-i is substituted to the 4-position of the catechol ring. Thus, it is particularly preferred that the monosubstituted catechol is 4- fe/f-butylcatechol.
  • Non-limiting examples of the structures of the monosubstituted catechols according to the present invention are provided in Table 1.
  • some compounds according to the invention have a weaker odour, when compared to that of thymol, or an odour which can be more appreciable to the consumer, when dosed into the compositions according to the invention at efficacious levels.
  • This benefit especially applies to for instance 4-ie/f-butylcatechol, which only has a weak odour.
  • compositions comprising enantiomerically pure radicals, racemic mixtures and other mixtures of different stereoisomers are equally preferable.
  • the extent to which the monosubstituted catechols according to the present invention are soluble in water or in organic solvents can be suitably expressed by the logarithm of the octanol/water partitioning coefficient, log ⁇ P ⁇ .
  • This partition coefficient is a measure for the distribution of a solute between water and octanol at equilibrium.
  • the value of the partitioning coefficient can also be predicted using computational methods. A commonly used predicted value is the so-called AlogP value.
  • a definition and preferred method of calculation of AlogP values is provided in A.K. Ghose, V.N.
  • AlogP values of different compounds can be compared with one another and used to assess the similarity of or difference between different compounds. For instance, phenol has an AlogP value of 1 .59 and thymol has an AlogP value of 3.27. Such comparison may also extend to other properties that are believed to be related to the same molecular properties that are believed to be related to the same molecular properties that underlie the value of AlogP.
  • the monosubstituted catechols according to the present invention preferably have an AlogP value of between 2.0 and 4.5, more preferably between 2.2 and 4.4, even more preferably between 2.4 and 4.1 and still more preferably between 2.5 and 4.0.
  • Suitable monosubstituted catechols according to the present invention may be commercially sourced or obtained via synthetic chemical methods. Such methods are generally well-known to the person skilled in the art.
  • the antimicrobial composition according to the invention comprises 0.001 to 5% by weight of terpineol.
  • the composition comprises preferably 0.005 to 4.5 wt-%, more preferably 0.01 to 4 wt-%, even more preferably 0.02 to 3 wt-%, yet more preferably 0.03 to 2 wt-%, still more preferably 0.04 to 1 wt-%, still more preferably 0.05 to 0.75 wt-% and even more preferably 0.1 to 0.5 wt-% of terpineol.
  • the minimum preferred concentrations of the terpineol can be higher, for the same reasons as for the monosubstituted catechols.
  • compositions according to the invention intended for dilution upon use preferably comprise 0.05 to 4.5 wt-%, more preferably 0.1 to 4 wt-%, even more preferably 0.2 to 3 wt-%, still more preferably 0.4 to 1 wt-%, and still more preferably 0.5 to 1 wt-% of the terpineol.
  • concentrations ranges for the terpineol is preferably combined with any of the concentration ranges for the one or more monosubstituted catechols specified above. Therefore, the antimicrobial composition according to the invention for example comprises:
  • the terpineol can be a single compound or a mixture of the terpineol isomers as detailed below. Mixtures of terpineols are preferred, since such mixtures may show increased antimicrobial activity against a wider range of microbes.
  • the composition according to the invention comprises such a mixture of terpineols, the mixture preferably comprises at least 30%, more preferably at least 50%, even more preferably at least 70% and still more preferably at least 90% by weight of one terpineol isomer with respect to the total weight of the terpineol.
  • said one terpineol isomer is alpha-terpineol.
  • the preferred concentrations ranges of the terpineol are important for the same reasons as the preferred concentration ranges of the one or more monosubstituted catechols in meeting the desired fast acting antimicrobial kinetics while not being sensorially unpleasant when used in products for personal cleaning, oral care or hard surface cleaning applications.
  • Terpineol exists as different isomers, which all are considered terpineols.
  • the terpineol is selected from the group consisting of alpha-terpineol, beta- terpineol, gamma- terpineol, delta- terpineol, 4- terpineol, and mixtures thereof. More preferably, the terpineol is selected from the group consisting of alpha-terpineol, beta- terpineol, gamma- terpineol, delta- terpineol, and mixtures thereof.
  • the isomeric compounds alpha-terpineol, beta-terpineol and gamma-terpineol are among the most abundant terpineols and often occur together in mixtures. Therefore even more preferably, the terpineol is selected from the group consisting of alpha-terpineol, beta- 5 terpineol, gamma-terpineol, and mixtures thereof.
  • the structures of these isomers are schematically depicted in Table 2 below.
  • compositions comprising enantiomerically pure radicals, racemic mixtures and other mixtures of different stereoisomers are equally preferable.
  • terpineol isomers which may be defined as monohydroxy alcohol derivatives of p-menthene, with the generic formula Ci 0 H 17 OH.
  • Combinations of these terpineol isomers are often found together in nature, because it is generally believed that their biosyntheses proceed via closely related synthetic pathways. Without wishing to be bound by theory, it is believed that the mode of antimicrobial action of these terpineol isomers in combination with the monosubstituted catechols according to the present invention is similar.
  • terpineols may also be referred to by the alternative names as detailed below in Table 3.
  • Terpineol may be added to the antimicrobial composition in purified form.
  • pine oil comprising terpineol may be added to the antimicrobial composition while ensuring that terpineol is present in the desired concentration in the composition of the present invention.
  • the antimicrobial composition according to the invention comprises a carrier.
  • the carrier is preferably selected from the group consisting of water, oil, solvent, inorganic particulate material, starch, air and mixtures thereof.
  • the carrier is preferably from 0.1 to 99% by weight of the composition.
  • the antimicrobial composition may be in form of a solid, liquid, gel, paste or soft solid and the carrier may be selected by a person skilled in the art depending on the format of the antimicrobial composition.
  • oils examples include mineral oils, oils of biological origin (e.g. vegetable oils), and petroleum-derived oils and waxes.
  • the oils of biological origin are preferably triglyceride-based.
  • the carrier oil is not a perfume oil.
  • the carrier oil preferably does not substantially contribute to the odour of the composition, more preferably it does not contribute to that odour.
  • solvents include alcohols, ethers and acetone.
  • the starch may be natural starch obtained from food grains or may be a modified starch.
  • suitable solvents include, for example, water;
  • glycols including ethylene glycol, propylene glycol, diethylene glycol, dipropylene glycol, polyethylene glycol, and polypropylene glycol; glycol ethers; alcohols, such as methanol, ethanol, propanol, phenethyl alcohol and phenoxypropanol; ketones, including acetone and methyl ethyl ketone; esters, including ethyl acetate, butyl acetate, triacetyl citrate, and glycerol triacetate; carbonates, including propylene carbonate and dimethyl carbonate; and mixtures thereof.
  • the solvent is selected from water, glycols, glycol ethers, esters and mixtures thereof.
  • suitable solid carriers include, for example, cyclodextrin, silicas, diatomaceous earth, waxes, cellulosic materials, alkali and alkaline earth (e.g., sodium, magnesium, potassium) metal salts (e.g., chloride, nitrate, bromide, sulfate) and charcoal.
  • alkali and alkaline earth e.g., sodium, magnesium, potassium
  • metal salts e.g., chloride, nitrate, bromide, sulfate
  • Air can for instance be used as a carrier when the monosubstituted catechols according to the invention and/or the terpineol are atomised or otherwise dispersed as a fine mist.
  • the antimicrobial composition may be formulated with either an aqueous base or a oil/solvent base.
  • Compositions with an aqueous base may also for instance be products in gel format.
  • Compositions with a purely oil/solvent base may for instance be products in anhydrous stick form or propellant-containing products.
  • the antimicrobial composition may for instance, preferably be an antimicrobial anhydrous stick personal care composition on a purely oil/solvent base wherein the composition has a water content of less than 0.01 % by weight, and wherein the composition preferably is free of water.
  • the antimicrobial composition may for instance, preferably be an antimicrobial propellant-drivable personal care composition, also comprising a propellant. Air can also be used as propellant, for instance in the form of compressed or liquefied air.
  • the most preferred product format has an emulsion base (water and/or oil being the carrier) or is capable of forming an emulsion upon dilution, e.g.
  • soap products in liquid, solid, lotion or semisolid form for hand wash, face wash, body wash, or shaving applications; toothpaste/ dentifrices for oral care applications or products for hard surface cleaning in bars or liquids form.
  • the product comprises an emulsion base, it preferably also comprises one or more surfactants as described below.
  • the antimicrobial composition according to the invention preferably comprises from 1 to 80% by weight of one or more surfactants.
  • Surfactants may for instance
  • the antimicrobial composition according to the invention preferably comprises a. 0.001 to 5% by weight of the one or more monosubstituted catechols
  • the antimicrobial composition comprises from 1 to 80% by weight of one or more surfactants in combination with the one or more
  • the surfactants may be chosen from the surfactants described in well-known textbooks like "Surface Active Agents” Vol. 1 , by Schwartz & Perry, Interscience 1949, Vol. 2 by Schwartz, Perry & Berch, Interscience 1958, and/or the current edition of "McCutcheon's Emulsifiers and Detergents” published by Manufacturing Confectioners Company or in "Tenside-Taschenbuch", H. Stache, 2nd Edn., Carl Hauser Verlag, 1981 ; "Handbook of Industrial Surfactants” (4th Edn.) by Michael Ash and Irene Ash; Synapse Information Resources, 2008. Any type of surfactant, i.e.
  • anionic, cationic, nonionic, zwitterionic or amphoteric can be used.
  • the one or more surfactants are anionic, nonionic, or a combination of anionic and nonionic surfactants. More preferably, the one or more surfactants are anionic.
  • a particularly preferred surfactant is soap.
  • Soap is a suitable surfactant for personal washing applications of the antimicrobial composition of the invention.
  • the soap is preferably C 8 -C 2 4 soap, more preferably a Ci 0 -C 2 o soap and most preferably Ci 2 -Ci 6 soap.
  • the soap may or may not have one or more carbon-carbon double bonds or triple bonds.
  • the cation of the soap can for instance be an alkali metal, alkaline earth metal or ammonium.
  • the cation of the soap is selected from sodium, potassium or ammonium. More preferably the cation of the soap is sodium or potassium.
  • the soap may be obtained by saponifying a fat and/or a fatty acid.
  • the fats or oils may be fats or oils generally used in soap manufacture, such as tallow, tallow stearines, palm oil, palm stearines, soya bean oil, fish oil, castor oil, rice bran oil, sunflower oil, coconut oil, babassu oil, palm kernel oil, and others.
  • the fatty acids are derived from oils/fats selected from coconut, rice bran, groundnut, tallow, palm, palm kernel, cotton seed, soyabean, castor etc.
  • the fatty acid soaps can also be synthetically prepared (e.g. by the oxidation of petroleum or by the hydrogenation of carbon monoxide by the Fischer-Tropsch process). Resin acids, such as those present in tall oil, may be used. Naphthenic acids are also suitable.
  • Tallow fatty acids can be derived from various animal sources. Other similar mixtures, such as those from palm oil and those derived from various animal tallow and lard are also included.
  • a typical fatty acid blend consists of 5 to 30%-wt coconut fatty acids and 70 to 95%-wt fatty acids ex hardened rice bran oil. Fatty acids derived from other suitable oils/fats such as groundnut, soybean, tallow, palm, palm kernel, etc. may also be used in other desired proportions.
  • the soap when present in solid forms of the present invention, is preferably present in an amount of 30 to 80%, more preferably from 50 to 80%, and even more preferably 55 to 75% by weight of the composition.
  • the soap, when present in liquid forms of the composition is preferably present in 0.5 to 20%, more preferably from 1 to 10% by weight of the composition.
  • Other preferred surfactants are fatty acid glycinates and fatty amphocarboxylates.
  • the fatty acid glycinates are fatty acid amides of salts of glycine, including for example sodium cocoyl glycinate.
  • the fatty amphocarboxylates are amphoteric surfactants including for example sodium lauroamphoacetate (i.e. sodium 2-[1 -(2-hydroxyethyl)-2- undecyl-4,5-dihydroimidazol-1 -ium-1 -yl]acetate).
  • suitable surfactants are derivatives of isethionates, including acylisethionates.
  • the antimicrobial composition of the invention is also useful in hard surface cleaning applications.
  • preferred surfactants are nonionic surfactants, such as C 8 -C 2 2, preferably C 8 -Ci 6 fatty alcohol ethoxylates, comprising between 1 and 8 ethylene oxide groups when the product is in the liquid form.
  • surfactants are preferably selected from primary alkyl sulphates, secondary alkyl sulphonates, alkyl benzene sulphonates, ethoxylated alkyl sulphates, or alcohol ethoxylate nonionic surfactants.
  • the composition may further comprise an anionic surfactant, such as alkyl ether sulphate preferably those having between 1 and 3 ethylene oxide groups, either from natural or synthetic source and/or sulphonic acid. Especially preferred are sodium lauryl ether sulphates. Alkyl polyglucoside may also be present in the composition, preferably those having a carbon chain length between C6 and C16.
  • Other classes of useful surfactants include cationic surfactants, such as long chain quaternary ammonium compounds and amphoteric surfactants such as betaines and alkyl dimethyl amine oxides.
  • Suitable surfactant concentrations in liquid forms of hard surface cleaning application are generally from about from 0.5 to 10%, preferably from 1 to 5 % by weight of the composition. In solid compositions, surfactant is preferably present in 5 to 40%, preferably from 10 to 30% by weight of the composition.
  • the antimicrobial composition of the invention is useful in oral care compositions e.g. in a dentifrice/ toothpaste or an oral rinse product.
  • preferred surfactants are anionic, nonionic or amphoteric in nature, preferably anionic or amphoteric.
  • the anionic surfactant is preferably an alkali metal alkyl sulphate, more preferably a sodium lauryl sulphate (SLS). Mixtures of anionic surfactants may also be employed.
  • the amphoteric surfactant is preferably a betaine, more preferably an alkylamidopropyl betaine (wherein the alkyl group is a linear Ci 0 -Ci 8 chain), and most preferably is cocoamidopropyl betaine (CAPB). Mixtures of amphoteric surfactants may also be employed.
  • Suitable surfactant concentrations in oral care application are generally from about 2% to about 15%, preferably from about 2.2% to about 10%, more preferably from about 2.5 to about 5% by weight of the
  • the antimicrobial compositions include soap, alkyl sulphate or linear alkyl benzene sulphonate as the surfactants. More preferably, the one or more surfactants are selected from the group consisting of soaps, alkyl sulphates and linear alkyl benzene sulphonates.
  • the antimicrobial composition may be in form of a solid, a liquid, a gel or a paste.
  • a person skilled in the art can prepare compositions in various formats by choosing one or more carrier materials and/or surfactant.
  • the antimicrobial compositions of the present invention are useful for cleansing and care, in particular for skin cleansing and skin care. It is envisaged that the antimicrobial composition can be used as a leave-on product or a wash-off product, preferably a wash-off product.
  • the antimicrobial composition of the present invention can also be used for cleansing and care of hard surfaces such as glass, metal, plastic and the like.
  • a particularly preferred carrier is water. When water is present, it is preferably present in at least 1 %, more preferably at least 2%, further more preferably at least 5% by weight of the composition. When water is the carrier, both liquid and solid
  • a preferred liquid antimicrobial composition according to the invention comprises:
  • liquid antimicrobial composition is useful for skin cleansing, in particular for hand wash or a face wash.
  • a preferred solid antimicrobial composition according to the invention comprises:
  • the solid antimicrobial composition is preferably in form of a shaped solid, more preferably a bar.
  • the solid antimicrobial composition is particularly useful for skin cleansing in particular for hand wash or a face wash.
  • Such a bar-shaped solid antimicrobial composition may for instance be a soap bar.
  • Soap bar compositions are well-known and may be similar to the following non-limiting example composition, comprising 75.6 wt-% of anhydrous sodium soap, 1 .0 wt-% of glycerine, 0.5 wt-% of sodium carbonate, 0.2 wt-% of EHDP (ethane-1 -hydroxy-1 ,1 - disphosphonate) acid, 0.04 wt-% of EDTA (ethylenediaminetetraacetic acid) tetrasodium salt, 8.5 wt-% of hydrated magnesium silicate (Talc), 0.7 wt-% of sodium chloride, 0.05 wt-% of dyes, 0.75 wt-% perfume, 0.05 to 10 wt-% of antimicrobial agents including the monosubstituted catechols and the terpineol according to the present invention, and water up to 100 wt-%.
  • inorganic particulate material is also a suitable carrier.
  • the antimicrobial composition is in a solid form.
  • the inorganic particulate material is talc.
  • the solid antimicrobial composition is particularly useful as a talcum powder for application on face or body.
  • a solvent different from water is a preferred carrier.
  • alcohol is a preferred solvent.
  • Short chain alcohols -in particular ethanol, propanol, and isopropanol- are particularly preferred as carrier for an antimicrobial wipe or an antimicrobial hand sanitiser composition.
  • Solvents like ethanol and isopropanol generally show antimicrobial efficacy themselves. However, they are also volatile and may readily evaporate during application of the composition. Thus, their levels on the surface that is treated might even reduce until below the minimum level required for antimicrobial action, before the minimum period needed for disinfection has passed. In contrast, the terpineol and the monosubstituted catechols according to the present invention are much less volatile and may therefore yield prolonged antimicrobial action after applying them to the skin. Additional ingredients
  • composition may further comprise various additional ingredients known to a person skilled in the art.
  • additional ingredients include but are not limited to: perfumes, pigments, preservative, emollients, sunscreens, emulsifiers, gelling agents, thickening agents, humectants (e.g. glycerine, sorbitol), sequestrants (e.g. EDTA) or polymers (e.g. cellulose derivatives for structuring such as methyl cellulose)
  • Both terpineol and some of the monosubstituted catechols according to the invention may contribute to the olfactory properties of the composition. Although some of these compounds might be applied for instance in perfume compositions, the present invention is directed towards antimicrobial compositions. Therefore, the composition is preferably not a perfume composition, although other perfume components can be present.
  • a perfume composition is defined as a composition comprising a plurality of olfactory components, wherein the composition is solely intended to provide a harmonious scent.
  • the inventors have surprisingly found that while one or more of the monosubstituted catechols according to the present invention alone or terpineol alone do not individually provide the fast antimicrobial kinetic action, a combination of one or more
  • the antimicrobial action of two or more active compounds is considered additive if the combined action merely results from the addition of the effects the individual components would have in isolation.
  • the antimicrobial action of two or more active compounds is considered to be synergistic if the combined effect of the two or more compounds is stronger than expected based on the assumption of additivity.
  • the antimicrobial action of the one compound may be enhanced by the action of the other compound and vice versa. Such enhancement may for instance originate from cooperative interplay between the mechanisms of antimicrobial action at the molecular level. Such enhanced
  • antimicrobial action may manifest itself for instance by the fact that lower
  • concentrations of active compounds are required to obtain complete microbial kill, or alternatively, that the same extent of microbial kill is arrived at in a shorter time.
  • an antimicrobial composition comprising two or more active compounds is capable of synergistic antimicrobial action may for instance be determined following the procedures and using the criteria as outlined in Example 1 below. Typically, evidence of synergistic antimicrobial action may be provided at concentrations below the minimum biocidal concentrations of each of the components when taken individually. However, it is generally believed that synergistic action can still occur when the concentration of one or more of the active compounds is raised above its minimum biocidal concentration (when taken individually).
  • the antimicrobial composition according to the present invention preferably comprises the one or more monosubstituted catechols and terpineol according to the invention at concentrations at which they are capable of synergistic antimicrobial action.
  • the concentrations of the one or more monosubstituted catechols and of the terpineol in the antimicrobial composition are preferably such that, when the composition is diluted or dissolved with a suitable medium during use, (e.g. when washing hands with water and a composition according to the invention) the concentration in the diluted or dissolved mixture is still sufficient to be antimicrobially efficacious.
  • the concentrations of the one or more monosubstituted catechols and the terpineol in the composition are preferably such that upon application, at a given concentration of the one or more monosubstituted catechols in the application medium (C mec i, monosubstituted catechols), the terpineol is available at at least a minimum medium concentration (C me d, t erp ) or vice versa (i.e. such that at a given C me d,terp, a minimum C me d,catechoi is available, sufficient to provided synergistic antimicrobial action).
  • the application medium denotes the medium in which the antimicrobial action desirably takes place.
  • the composition may be a solid soap bar.
  • C CO mp refers to the concentration of the component in the soap bar
  • C me d refers to the concentration in the lather.
  • the minimum and optimum concentrations may for instance be determined by a protocol as described for Example 1 or by one of the standards as detailed below. It is generally preferred that the concentrations of the one or more monosubstituted catechols and the terpineol in the composition according to the invention are equal to or higher than the optimal concentrations in the application medium, because in many typical applications, the composition is either used pure or is diluted to form the application medium.
  • the synergy between the monosubstituted catechols and terpineol in compositions according to the invention occurs over a wide range of concentrations and concentration ratios.
  • concentrations and concentration ratios Depending on factors including the type of antimicrobial composition, its intended application (for instance a hard surface cleaner, a skin cleanser, or a hand sanitiser) different concentration ranges and ratios will be preferred.
  • Example 1 when for instance antimicrobial action against E. Coli is desired, the data of Example 1 may be used to determine preferable medium concentrations C mec i-
  • the monosubstituted catechol is 4-ie f-butylcatechol
  • C me d,catec h oi is selected as 0.025 %(w/v)
  • C mec i , t er preferably is at least 0.4 %(w/v) and vice versa.
  • the desired antimicrobial effect may be obtained by selecting a ratio of the respective concentrations of the one or more monosubstituted catechols and the terpineol.
  • a concentration ratio of the intended antimicrobial efficacy and other considerations including for instance sensory properties, solubility, economic considerations, a concentration ratio of the intended antimicrobial efficacy and other considerations, including for instance sensory properties, solubility, economic considerations, a concentration ratio of
  • the antimicrobial composition according to the invention preferably comprises the one or more monosubstituted catechols and the terpineol in a concentration ratio (monosubstituted catechols:terpineol) of between 1 :2 and 1 :12, wherein the concentration is expressed as weight percent.
  • the antimicrobial composition according to the invention preferably comprises the one or more monosubstituted catechols and terpineol in an applicable concentration ratio as specified hereinbelow.
  • the synergistic antimicrobial composition comprises 4-ferf-butylbenzene-1 ,2-diol and alpha-terpineol.
  • a weight ratio of 4-ie f-butylbenzene-1 ,2-diol to alpha-terpineol is from 1/0.06 to 1/1.5. More preferably, a weight ratio of 4-tert-butylbenzene-1 ,2-diol to alpha-terpineol is either from 1/0.03 to 1/0.06 or from 1/0.75 to 1/1 .5.
  • a further additional advantage of the present invention is that it is observed that treatment of a surface with a composition according to the invention comprising one or more monosubstituted catechols and terpineol, surprisingly enables continued protection of the surface against growth of microbes for a substantial period of time thereafter.
  • compositions suitable in wash-off processes as described above include a surfactant for the cleaning action.
  • a surfactant for the cleaning action.
  • the surfactant alone does not provide the fast antimicrobial kill at the concentration present in wash off processes, it provides for further improvement in extent of reduction in viable microbial counts on the surface in the short period of time when surfaces are washed with a composition comprising one or more monosubstituted catechols, terpineol and additionally surfactant.
  • surfactant is generally known to be responsible for washing off dirt and also antimicrobial actives used in the composition, in the present invention, it provides a highly useful additional benefit in that it enhances the reduction of viable microbial count in a composition comprising a combination of monosubstituted catechols and terpineol alone.
  • composition according to the invention preferably comprises 4-ie f-butylcatechol. More specifically, it is preferred that in case the composition according to the invention comprises a surfactant selected from cocoyl glycinate and lauroamphoacetate, the monosubstituted catechol is 4-ie f-butylcatechol.
  • the invention relates to a method of disinfecting a surface comprising the steps of
  • the surface is skin.
  • a surface like the hands, face, body, or the oral cavity is contacted with the composition of the invention.
  • the method preferably is a non-therapeutic method of disinfecting a surface.
  • the surface is any hard surface.
  • such hard surfaces are surfaces that commonly require cleaning and preferably also require sanitisation or disinfection.
  • Such surfaces may be found in many household or industrial environments, and may include for example kitchen and bathroom surfaces, table tops, floors, walls, windows, utensils, cutlery, and crockery.
  • Such surfaces may be made from many different materials, including for instance plastics, wood, metal, ceramics, glass, concrete, marble, and painted surfaces.
  • composition may be applied to the surface by any suitable means known to the skilled person.
  • a suitable means may be pouring, dropping, spraying or wiping in case of liquid compositions.
  • the method includes diluting or dissolving the composition with a suitable solvent, preferably water, before or whilst applying the composition to the surface.
  • a suitable solvent preferably water
  • Such dissolving is preferred in particular in case the composition is a solid composition.
  • solid compositions may also be directly spread, rubbed, or sprayed, e.g. in the form of a powder.
  • the method according to the first aspect of the present invention also includes the step of removing the composition from the surface.
  • removing the composition also encompasses partially removing the composition, because traces of the composition may remain on the surface. In many typical situations, such as washing of the skin or hard-surface cleaning, it is acceptable or sometimes even desirable if part of the composition - in particular certain active ingredients - remains on the surface.
  • step b preferably involves removing at least 5%, more preferably at least 10%, even more preferably at least 25%, still more preferably at least 50% and yet more preferably at least 75% of the composition by weight.
  • the step of removing the composition comprises rinsing the surface with a suitable solvent or wiping the surface with a suitable wipe, more preferably, this step consists of rinsing the surface with a suitable solvent or wiping the surface with a suitable wipe.
  • the removal step can also include evaporation of part of the composition, for example when the composition comprises volatile components, e.g. solvents.
  • a suitable medium for rinsing the surface is water but it could also be for example a mixture of water and alcohol. It is then rinsed preferably with sufficient amounts of water after a pre-determined period of time to remove any visible or sensory residue of the composition.
  • an alcohol wipe or a water/alcohol impregnated wipe may be used to wipe the surface to be visibly free of the anti-microbial composition. The step of removing the composition (e.g.
  • the step of removing the composition from the surface is started out at least 5 seconds, preferably at least 10 seconds, more preferably at least 15 seconds after commencement of the step of applying the composition on the surface, in order to effect optimal antimicrobial action. Combinations of these times into time intervals are preferred too.
  • the step of removing the composition from the surface is started between 2 minutes and 5 seconds, more preferably between 1 minute and 10 seconds, even more preferably between 30 and 10 seconds and still more preferably between 20 and 15 seconds after commencement of the step of applying the composition on the surface (i.e. step a).
  • the invention preferably relates to a method, wherein the disinfection time T of said method is less than 300 seconds, preferably less than 60 seconds, and more preferably less than 15 seconds; wherein T is defined as the time that elapses from the moment of adding the composition to a microbial culture until the number of microbes per unit volume of the culture is reduced by a factor of 100 000; and wherein the initial number of microbes preferably exceeds about 100 000 000 microbes per millilitre and wherein the composition is preferably a liquid composition.
  • the disinfecting action of the method (as may be expressed in terms of the disinfection time T) is preferably determined according to the protocol of Example 1 as described hereinafter.
  • This test relates to a standardised test environment in which the microbial culture is kept in suspension.
  • a similarly suitable test is the standard suspension method described in European Standard EN 1276, with the proviso that the disinfection time is adapted to suit the above criteria as will be clear to a person skilled in the art.
  • one of the test methods as described in WO 2010/046238 may for instance be applied to establish the disinfecting action.
  • test methods may preferably also be used by the skilled person to determine the optimal concentrations of the one or more monosubstituted catechols and the terpineol in an antimicrobial composition according to the present invention.
  • the disinfection time may also be determined by test methods involving a surface. Therefore, the invention preferably relates to a method according to the present invention, wherein the surface disinfection time T2 of said method is less than 60 seconds, preferably less than 15 seconds, wherein T2 is defined as the time starting from the moment of applying the composition to the surface to be disinfected after which the number of microbes per unit area is reduced by a factor of 10000 (i.e.
  • microbes preferably exceeds 10 3 , more preferably 10 5 , and even more preferably 10 7 microbes per square centimeter.
  • Such tests may for instance be performed as described in WO 2010/046238, or as described in European Standards EN 13697:2001 and EN 1500:1997.
  • the invention preferably provides for non-therapeutic benefits.
  • the invention relates to use of an antimicrobial composition according to the present invention for faster reduction in viable microbial count.
  • a composition according to the invention for improved hygiene.
  • Such use relates for example to use of an antimicrobial composition comprising the one or more
  • the disinfection time is less than 300 seconds, preferably less than 60 seconds, and more preferably less than 15 seconds.
  • the disinfection is preferably defined similar to the disinfection times T and T2 as described above.
  • compositions according to the invention for improved hygiene of surfaces of the human body.
  • Such surfaces include e.g. skin, hands and the oral cavity.
  • the invention relates to use of a composition according to the invention for improved hand hygiene.
  • the invention relates to use of a composition according to the invention for improved oral hygiene.
  • the microbicide compositions of the present invention can be used to inhibit the growth of microorganisms by introducing a microbicidally effective amount of the compositions onto, into or at a locus subject to attack.
  • suitable loci include, for example: industrial process water including electrocoat deposition systems, cooling towers and air washers; gas scrubbers; wastewater treatment; ornamental fountains; reverse osmosis filtration; ultrafiltration; ballast water; evaporative condensers and heat exchangers; pulp and paper processing fluids and additives; mineral slurries; starch; plastics; emulsions; dispersions; paints; latices; coatings, such as varnishes; construction products, such as mastics, caulks, and sealants; construction adhesives, such as ceramic adhesives, carpet backing adhesives, and laminating adhesives; industrial or consumer adhesives; photographic chemicals; printing fluids; household and institutional products used in restaurants, healthcare facilities, schools, food processing facilities and farms including, cleaners, sanitizers and disinfectants, wipes, soaps, detergents, floor polishes and laundry rinse water; cosmetics; toiletries; shampoos; metalworking fluids; conveyor lubricants;
  • the microbicidal compositions of the present invention are used to inhibit the growth of microorganisms at a locus selected from one or more of mineral slurries, pulp and paper processing fluids and additives, starch, emulsions, dispersions, paints, latices, coatings, construction adhesives (such as ceramic adhesives), carpet backing adhesives, photographic chemicals, printing fluids, household and institutional products such as cleaners, sanitizers, disinfectants, wipes, cosmetics, toiletries, shampoos, soaps, detergents, floor polishes, laundry rinse water, metal working fluids, textile products, wood and wood products, agriculture adjuvant preservation, surfactant preservation, diagnostic reagent preservation, food preservation, food, beverage, and industrial process pasteurizers and oil and gas processing fluids.
  • a locus selected from one or more of mineral slurries, pulp and paper processing fluids and additives, starch, emulsions, dispersions, paints, latices, coatings, construction adhesives (such
  • composition according to the invention can in view of the above be applied for disinfection, reduction in viable microbial count or improved hygiene, especially at a surface.
  • the composition is particularly suited for application to the skin.
  • a surface like the hands, face, body, or the oral cavity can suitably be contacted with the composition of the invention.
  • the surface is any hard surface.
  • such hard surfaces are surfaces that commonly require cleaning and often also require sanitisation or disinfection. Such surfaces can be found in many household or industrial
  • compositions can be used for such disinfection, reduction in viable microbial count or improved hygiene at loci other than the surfaces as described hereinbefore.
  • the invention relates to compositions according to the invention for use as or incorporation in home care products and personal care products. More preferably, this embodiment of the invention relates to a composition according to the invention which is a home care product or a personal care product.
  • a "home care product” is a product for the treatment, cleaning, caring or conditioning of the home or any of its contents.
  • the foregoing includes, but is not limited to, compositions, products, or combinations thereof relating to or having use or application in the treatment, cleaning, cleansing, caring or conditioning of surfaces, furniture and atmosphere of the home and household contents, such as clothes, fabrics and/or cloth fibres and the manufacture of all of the foregoing products.
  • a "personal care product” is a product for the treatment, cleaning, caring or conditioning of the person.
  • the foregoing includes, but is not limited to, chemicals, compositions, products, or combinations thereof relating to or having use or application in the treatment, cleaning, cleansing or conditioning of the person (including in particular the skin, hair and oral cavity), and the manufacture of all the foregoing.
  • Home care products and personal care products are for example products marketed under mass market brands, non- limiting examples being soap bars, deodorants, shampoos, and home surface sanitisers/disinfectants.
  • compositions according to the invention for use as or incorporation in industrial and/or institutional products. More preferably, this embodiment of the invention relates to a composition according to the invention which is an industrial and/or an institutional product.
  • Industrial and institutional products are for example products being marketed under professional brands, non-limiting examples being for industrial, institutional, janitorial, and medical cleaning, cleaning-in-place, food services, veterinary, and agricultural products.
  • Industrial and/or institutional products also include products for cleaning of the person (such as hand sanitisers) for medical offices, hospitals and/or other institutions.
  • the invention also relates to a method or use according to the invention involving home care products or personal care products.
  • the method according to the invention - which comprises application of a composition according to the invention in step a - can be a method wherein that composition is a composition for use as or incorporation in home care products and personal care products as described hereinabove.
  • the invention also relates to a method or use according to the invention involving industrial and/or institutional products.
  • the method according to the invention - which comprises application of a composition according to the invention in step a - can be a method wherein that composition is a composition for use as or incorporation in industrial and/or institutional products as described hereinabove.
  • Products and/or methods for use in the home care or personal care field are generally distinct from products and/or methods for use in the industrial and/or institutional field.
  • a product that is marketed as a home or personal care product will generally not be marketed as a product for industrial and/or institutional use and vice versa. Therefore, certain embodiments of the present invention, when carried forth into practice, will relate to the one field, but not the other.
  • 4-Terf-butylcatechol was purchased as fine chemical from suppliers such as Sigma Aldrich, Alfa Aesar and TCI Fine Chemicals.
  • a terpineol mixture comprising ca 88 wt-% of (S)-alpha-terpineol, and 12 wt-% of gamma-terpineol was purchased from Sigma Aldrich and used throughout the examples (being referred to as alpha-terpineol or terpineol) unless specified otherwise.
  • MBC Minimum Biocidal Concentration
  • Fractional Biocidal Concentration (FBC)
  • the interactions between antimicrobials can be additive, synergistic or possibly antagonistic depending on whether the efficacy of the combination is equivalent to, greater than or less than that obtained for the same total concentration of the individual components when tested alone.
  • ⁇ FBC ⁇ 1 corresponds to additive or antagonistic bactericidal activity
  • ⁇ FBC ⁇ 1 corresponds to synergistic bactericidal activity
  • Antimicrobial efficacy is tested against a representative pathogenic bacterial organism, Gram negative Escherichia coli. Concentrations of actives are expressed in terms of the percentage weight/volume (%w/v) throughout Example 1 .
  • the following assay describes the testing of 8 materials using 6 dilutions across half of a 96-well micro titre plate (MTP). Using this approach it is possible to assay 16 actives (without replicates) with one full dilution plate, replicating this set up in two halves of the plate columns, 1 -6 and 7-12.
  • D/E neutralising solution from DIFCO Composition was added to column 1 .
  • the composition of the neutralising solution was as follows: pancreatic digest of casein, 5.0g/L; Yeast Extract, 2.5 g/L; Dextrose, 10 g/L, sodium thioglycollate, 1.0 g/L, sodium thiosulphate, 6.0 g/L; sodium bisulphite, 2.5 g/L; Polysorbate 80, 5.0 g/L; lecithin 7.0 g/L; bromocresol purple, 0.02 10 g/L with a pH in the range 7.6 ⁇ 0.2.
  • Bacterial stock (30 ⁇ ) was then added to the prepared 270 ⁇ of the solution of actives in the Screening Plate and mixed, using a multichannel pipette with 8 tips to aspirate and dispense the same volume of bacterial stock in parallel to 8 wells in rows A-H. After a contact time of 15 seconds, the mixtures were quenched by transferring 30 ⁇ volumes of the mixtures into the 270 ⁇ D/E neutralising solution in the prepared dilution
  • TSA Tryptone Soya Agar
  • N M BS Mean bacterial survival numbers (expressed in Log CFU/ml) are obtained by first determining the segment of the TSA plate where the number of bacterial colonies is countable. From the colony number in this segment, N M BS is calculated by the formula:
  • NMBS log ⁇ Nee ⁇ 10 DF - 100 / 3 ⁇
  • N C0 is the colony count
  • DF is the dilution factor taken from the MTP-well corresponding to the TSA plate segment (i.e. DF may range from 1 for the quench, to 6 for the highest dilution).
  • the factor 100/3 is a conversion factor from the volume of the inocula spot to one millilitre.
  • control experiments A, B and D validate a test assay by not showing bacterial kill
  • control experiment C comprising a synergistic combination of thymol and alpha-terpineol according to WO 2010/046238 A1 validates a test assay by showing complete bacterial kill.
  • Table 5 shows the antibacterial activities of the monosubstituted catechols, both alone and in conjunction with terpineol.
  • Table 5 Antibacterial activities of thymol, and monosubstituted catechols alone and in combination with terpineol
  • MBCs Minimum Biocidal Concentrations
  • the MBC for an active can be defined as the lowest concentration of the active that provides zero bacterial bacterial survival in the particular medium.
  • Data for examples (1 :1 ) to (1 :3) demonstrate that the MBC value for thymol is 0.05% (w/v).
  • compositions (1 :4) to (1 :7) show that the MBC is 0.4% w/v.
  • 4-ie f-butylbenzen-1 ,2- diol summarised in Table 6 below.
  • the comparative examples (1 :12) to (1 :15) show that compositions comprising terpineol and monosubstituted benzenediols that are not compounds according to the present invention at concentrations comparable to those in the examples according to the invention do not give rise to fast antimicrobial action.
  • the comparative examples (1 :16), (1 :17), and (1 :18) show that benzene-1 ,2-diol is not capable of providing the desired fast antimicrobial action alone, and also does not show synergistic
  • Example 2 a wide range of combinations of chemicals was tested by conducting high resolution MBC assays of 4-ie f-butylbenzene-1 ,2-diol in the presence of various concentrations of terpineol.
  • the materials were sourced in the same way as for Example 1. Synergy tests were conducted using standard microtiter plate assays with phosphate buffer containing 35% dipropylene glycol (DPG).
  • High resolution MBCs were determined by adding varying amounts of microbicide to one column of a microtiter plate and doing subsequent ten-fold dilutions using an automated liquid handling system to obtain a series of endpoints ranging from 0.002% to 1 % of the test compound.
  • the MBC plate was inoculated one column at a time with the test microorganism. An aliquot of the inoculated well was transferred at 15 seconds to a plate containing a neutralizing agent (D/E Neutralizing Broth), mixed and held for 5 minutes before being transferred to a growth plate containing trypticase soy broth (TSB). The TSB plate was incubated at 37° C and read for the presence / absence of growth at 24 hours. The lowest level tested that provided complete kill (as evidenced by lack of growth on the microtitre plate) of the test organisms in 15 seconds is defined as the minimum biocidal concentration (MBC) throughout Example 2.
  • MBC biocidal concentration
  • the synergy of the combinations of the present invention was determined against a the same bacterium as in Example 1 , Escherichia coli (£. coli - ATCC #10536), at a concentration of approximately 1 x 10 8 bacteria per ml_.
  • microorganism is representative of natural contaminants in many consumer and industrial applications.
  • the plates were visually evaluated for microbial growth
  • the test results for demonstration of synergy of the combinations of the present invention are shown below in Table 8.
  • the table shows the specific combinations of two components; results against the microorganism tested; the end-point activity in weight % measured by the MBC for the first component alone (4-ie f-butylbenzene-1 ,2- diol, MBC A ), for the second component alone (terpineol, MBC B ), for the first component in the mixture (C a ) and for the second component in the mixture (C b ); the calculated ⁇ FBC value; and the range of synergistic ratios for each combination tested (first component to second component or A / B) against the particular microorganism.
  • microorganisms than would be expected if the combinations were additive rather than synergistic.
  • First Component (A) 4-ie f-butylbenzene-1 ,2-diol
  • Second Component (B) terpineol
  • Examples 1 and 2 demonstrate that a synergistic antimicrobial effect of monosubstituted catechols according to the invention and terpineol may be obtained over a wide range of concentrations and ratios.
  • the efficacy of combinations of monosubstituted catechols and terpineol were tested in a surfactant cleansing formulation comprising 2.85% sodium cocoyl glycinate and 1 .85% sodium lauroamphoacetate. This corresponds to a 50% in use dilution with water of a typical neat formulation containing 5.7% cocoyl glycinate and 3.7% % sodium lauroamphoacetate during hand washing. Solutions were prepared such that the concentrations of the surfactant components and test actives were 1 .1 times the final desired concentration in order to allow for dilution with the bacterial inoculum in the test.
  • the efficacy of the combinations of the present invention was determined against the same bacterium as in Example 1 , Escherichia coli (£. coli - ATCC #10536), at a concentration of approximately 1 x 10 8 bacteria per ml_.
  • Tests were conducted using standard microtiter plate assays using an automated liquid handling system. 270 ⁇ of the surfactant test solution was pipetted into each well of the microtitre plate (Nunc F Gamma Irradiated 96F untreated microtitre plates of clear polystyrene) and 30 ⁇ of the bacterial suspension was then added. After exactly 15 seconds of bacterial exposure, a 30 ⁇ volume of bacterial cells was withdrawn and transfered to 270 ⁇ of D/E quench solution. After 5 minutes in the D/E quench, the optical density (OD) was measured for each plate in turn at two specific wavelengths (450nm and 590nm).
  • OD 450 increases by less than 0.2 absorbance unit (AU) on incubation and (2).
  • OD 590 decreases by less than 0.35 AU on incubation.
  • test system allows bacterial growth and is not deemed efficacious.
  • Four replicate measurements in the same plate have been made for each test system. The number of replicate wells showing either bacterial growth or no growth is also readily assessed by eye by following the colour change. Thymol and terpineol were tested both alone and in combination for comparison purposes.
  • Table 9 Antibacterial activities of thymol, monosubstituted catechols alone, and in combination with terpineol in model surfactant solution.
  • the surfactants used are not themselves antimicrobially active against E. coli at the concentrations employed as shown by the results of Ex. (3:1 ) in Table 9. Thus, any antimicrobial efficacy can be ascribed to the monosubstituted catechols and/or terpineol.
  • Table 10 presents MBC-values determined similarly as described for Example 1 . The tested monosubstituted catechols have an MBC higher than the highest tested concentrations, in the presence of the specified surfactants.

Abstract

La présente invention concerne une composition antimicrobienne et un procédé de désinfection mettant en oeuvre la composition antimicrobienne. Elle concerne en particulier une composition antimicrobienne pour l'hygiène personnelle, les soins buccaux, ou des applications de nettoyage de surfaces dures. Il a été découvert que des compositions comprenant des catéchols monosubstitués, le terpinéol et un support présentent une action antimicrobienne synergique. Dans un aspect préféré, la composition comprend également 1 à 80% en poids d'un ou de plusieurs tensioactifs.
PCT/EP2012/074405 2011-12-06 2012-12-05 Composition antimicrobienne WO2013083584A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161567362P 2011-12-06 2011-12-06
US61/567,362 2011-12-06
EP12173843.9 2012-06-27
EP12173843 2012-06-27

Publications (1)

Publication Number Publication Date
WO2013083584A1 true WO2013083584A1 (fr) 2013-06-13

Family

ID=48573590

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/074405 WO2013083584A1 (fr) 2011-12-06 2012-12-05 Composition antimicrobienne

Country Status (1)

Country Link
WO (1) WO2013083584A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014082854A3 (fr) * 2012-11-29 2014-08-14 Unilever N.V. Compositions de nettoyage antibactériennes douces

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0259249A2 (fr) 1986-07-23 1988-03-09 Ciba-Geigy Ag Préparations microbicides
FR2697133A1 (fr) 1992-10-28 1994-04-29 Transbiotech Composition biocide et/ou biostatique et ses applications.
WO2004006876A1 (fr) 2002-07-15 2004-01-22 Unilever Plc Composition pour le traitement des cheveux et/ou du cuir chevelu
EP2042198A1 (fr) 2006-03-22 2009-04-01 Takasago International Corporation Composition desodirisante liquide et procede de desodorisation
WO2010046238A1 (fr) 2008-10-20 2010-04-29 Unilever Nv Composition antimicrobienne

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0259249A2 (fr) 1986-07-23 1988-03-09 Ciba-Geigy Ag Préparations microbicides
FR2697133A1 (fr) 1992-10-28 1994-04-29 Transbiotech Composition biocide et/ou biostatique et ses applications.
WO2004006876A1 (fr) 2002-07-15 2004-01-22 Unilever Plc Composition pour le traitement des cheveux et/ou du cuir chevelu
EP2042198A1 (fr) 2006-03-22 2009-04-01 Takasago International Corporation Composition desodirisante liquide et procede de desodorisation
WO2010046238A1 (fr) 2008-10-20 2010-04-29 Unilever Nv Composition antimicrobienne

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
"McCutcheon's Emulsifiers and Detergents", MANUFACTURING CONFECTIONERS COMPANY
A L GUNATILAKA: "Natural products in Plants: Chemical Diversity in the Wiley Encyclopedia of Chemical Biology", pages: 1 - 17
A.K. GHOSE; V.N. VISWANADHAN; J.J. WENDOLOSKI, J.PHYS.CHEM. A, vol. 102, 1998, pages 3762
E BREITMAIER: "Terpenes: flavors, fragrances, pharmaca, pheromones", 2006, WILEY-VCH, pages: 17
F HEUSLER: "The Chemistry of the Terpenes", 1902, P BLAKISTONS'S SON & CO, pages: 21
H. STACHE: "Tenside-Taschenbuch", 1981, CARL HAUSER VERLAG
J JENSEN: "Chlorophenols in the terrestrial environment", REVIEWS OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, vol. 146, 1996, pages 25 - 51
JP VOETS ET AL., J. APPL. BACT., vol. 40, 1976, pages 67 - 72
JRW LAMBERT; R LAMBERT, J. APPL. MICROBIOL, vol. 95, 2003, pages 734
MICHAEL ASH; IRENE ASH: "Handbook of Industrial Surfactants", 2008, SYNAPSE INFORMATION RESOURCES
P A GODDARD; K A MCCUE: "Disinfection, Sterilisation and Preservation", 2001, LIPPINCOTT, WILLIAMS AND WILKINS, pages: 255 - 282
SCHWARTZ; PERRY: "Surface Active Agents", vol. 1, 1949, INTERSCIENCE
SCHWARTZ; PERRY; BERCH: "SURFACE ACTIVE AGENTS", vol. 2, INTERSCIENCE
T. JADAVJI; CG PROBER; R CHEUNG, ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 26, 1984, pages 91

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014082854A3 (fr) * 2012-11-29 2014-08-14 Unilever N.V. Compositions de nettoyage antibactériennes douces
US9655866B2 (en) 2012-11-29 2017-05-23 Conopco, Inc. Mild antibacterial cleansing compositions

Similar Documents

Publication Publication Date Title
EP2787823B1 (fr) Composition antimicrobienne
US9271492B2 (en) Antimicrobial composition
EP2863750B1 (fr) Composition antimicrobienne
EP2787825B1 (fr) Composition antimicrobienne
US9247737B2 (en) Method for disinfecting a surface
WO2014001056A1 (fr) Composition antimicrobienne
EP2787820B2 (fr) Composition antimicrobienne
WO2014001057A1 (fr) Composition antimicrobienne
EP2866569B1 (fr) Composition antimicrobienne
EP2787821B1 (fr) Composition antimicrobienne
WO2013083584A1 (fr) Composition antimicrobienne
WO2013083582A1 (fr) Composition antimicrobienne
WO2014001059A1 (fr) Composition antimicrobienne
WO2013083585A1 (fr) Composition antimicrobienne
WO2014001052A1 (fr) Composition antimicrobienne

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12801720

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12801720

Country of ref document: EP

Kind code of ref document: A1